Adam Feuerstein is a Polk Award-winning biotech reporter at STAT News in Boston, MA, with over 119,000 followers. He specializes in in-depth coverage of biotechnology and pharmaceutical developments, including drug pricing reforms and clinical trial analyses. Feuerstein's work highlights significant medical research and industry trends, establishing him as a leading voice in biotech journalism.

‌